Inactive Instrument

Company SourcingLink.net, Inc. OTC Bulletin Board

Equities

US8361714053

Pharmaceuticals

Business Summary

Oncology Pharma, Inc. is an oncology company. The Company is focused on licensing, developing, manufacturing and commercializing therapeutics. The Company's research, development, and commercialization of therapeutic drugs and medical devices designed for the treatment of many types of cancers. The Company offers a portfolio, such as Nanosmart Pharmaceuticals Inc. (Nanosmart Pharmaceuticals). The Company's NanoSmart platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. Its anti-cancer drugs in combination with medications, for treating a variety of cancers, such as breast, ovarian, lung, bladder, Kaposi's sarcoma, lymphoma and acute lymphocytic leukemia is doxorubicin. Its portfolio also includes Connect2Med, Sybleu, Inc. and Regen.

Managers

Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 21-01-27
Chairman - 14-09-29
General Counsel - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 19-10-07
Chairman - 14-09-29
Director/Board Member - -
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 38,563,216 38,563,216 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
RFP Financial Group LLC
0.003556 %
974 0.003556 % - $

Company contact information

Oncology Pharma, Inc.

One Sansome Street Suite 3500

94104, San Francisco

+415-869-1036

http://www.oncology-pharma.com
address SourcingLink.net, Inc.